Activity and Safety of Bevacizumab Plus Fotemustine for Recurrent Malignant Gliomas

Figure 1

Before treatment MRI SE FLAIR (a) and T1 after contrast medium infusion (b) shows a large lesion in the left temporal lobe, hyperintense on FLAIR image with multiple focal enhancement areas after c.m. infusion. There is a compression on ventricle trigone. MRI FLAIR (c) and T1 (d) after contrast medium (c.m.), after treatment, show marked reduction of the hyperintensity area on the FLAIR sequence with disappearance of the enhancement areas on T1 sequence after c.m. The ventricle trigone is enlarged.